Abstract
Recently, Medisense has introduced the Sensorlink ™ system as a tool for retrieving the 125 last results of home blood glucose monitoring stored in patient's Pen ™ 2 or Companion ™ 2, unknown to them. Therefore we decided to check the compliance of type I diabetic adolescents and young adults with home blood glucose monitoring (HBGM) by comparing the blood glucose values noted in their log book and those retrieved by the Sensorlink ™ and to evaluate an eventual subsequent effect both on compliance and glycated haemoglobin (HbA 1c). The study was carried out in 60 insulin-dependent diabetes mellitus (IDDM) patients (33 women and 27 men) chosen according to two criteria: (1) the use of a Medisense Pen ™ 2 or Companion ™ 2; (2) autonomous self-monitoring of blood glucose, i.e. without parental supervision. They were aged 21.3 ± 6.3 years with a diabetes duration of 11.6 ± 7.0 years. HbA 1c was measured by an HPLC method (N: 4.4–6.0%) before and after the first use of the Sensorlink ™ and HBGM data of the log books were recorded. After the first use of the Sensorlink ™, the patients were warned of the retrieving data. The 60 patients were divided into two groups (same mean age and diabetes duration), according to the mean level of HbA 1c before Sensorlink ™: ≤7% (good control; n = 33); >7% (insufficient control; n = 27). Cheating was unrelated to sex and occurred in 36 patients (60%; aged: 19.3 ± 4.7 years), up to 100% in 13 of them (22%); five patients had no log book (8%; aged: 24.0 ± 5.0 years); 19 patients (32%; aged 24.4 ± 7.9 years) didn't cheat at all. After the use of the Sensorlink ™ system, cheating dramatically decreased to zero. The effect of the Sensorlink ™ system on improvement of HbA 1c was statistically significant in the 27 patients with insufficient control before Sensorlink ™, since mean HbA 1c level decreased from 8.0 ± 0.9% to 7.5 ± 1.1% ( P < 0.05). In conclusion, non compliance with HBGM occurs in 2 3 of adolescents and young adults with IDDM. The Sensorlink ™ system puts an end to this phenomenon and allows significant reduction of HbA 1c levels in patients with insufficient metabolic control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
